ImmuneRegen BioSciences is engaged in the research and development of the drug candidate, Homspera® for use as an immunomodulatory agent and stimulator of human adult stem cells. The company is focused on developing therapeutics aimed at specific disease targets including influenza, cancers (solid and blood), pulmonary fibrosis and neutropenia. Other areas of research for potential applications include stimulation of stem cells and wound healing. The company is also pursuing Homspera for use as a possible countermeasure for homeland security threats including radiation exposure, and chemical and biological agents.
View Top Employees from ImmuneRegen BioSciences| Website | http://www.immuneregen.com |
| Revenue | $18.6 million |
| Employees | 2 (1 on RocketReach) |
| Founded | 2001 |
| Address | 8767 E. Via De Ventura Ste. 190, Scottsdale, Arizona 85258, US |
| Phone | (480) 922-3926 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+8 more
(view full list)
|
| Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Biotechnology, Healthcare |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325412 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular ImmuneRegen BioSciences employee's phone or email?
ImmuneRegen BioSciences Questions
The ImmuneRegen BioSciences annual revenue was $18.6 million in 2024.
1 people are employed at ImmuneRegen BioSciences.
ImmuneRegen BioSciences is based in Scottsdale, Arizona.
The NAICS codes for ImmuneRegen BioSciences are [325412, 32541, 3254, 32, 325].
The SIC codes for ImmuneRegen BioSciences are [283, 28].
Related Companies
